77 FR 42 pg. 12844 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Reducing Health Disparities Among People With Intellectual Disabilities, FOA DD12-003, Initial Review
Type: NOTICEVolume: 77Number: 42Page: 12844
FR document: [FR Doc. 2012-5089 Filed 3-1-12; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Reducing Health Disparities Among People With Intellectual Disabilities, FOA DD12-003, Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 11 a.m.-5 p.m., April 25, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to "Reducing Health Disparities among People with Intellectual Disabilities, FOA DD12-003, initial review."
Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-46, Atlanta, Georgia 30341, Telephone: (770) 488-3585.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: February 23, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2012-5089 Filed 3-1-12; 8:45 am]
BILLING CODE 4163-18-P